Status:
COMPLETED
PPI for Prevention of Post-sphincterotomy Bleeding
Lead Sponsor:
The University of Hong Kong
Conditions:
Bleeding
ERCP
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Endoscopic biliary sphincterotomy is a common and important procedure for biliary access and therapy during endoscopic retrograde cholangiopancreatography (ERCP). Bleeding is one of the important comp...
Detailed Description
Eligible patients will be randomized to receive either high dose PPI or standard care. PPI will be given before ERCP and continue for one week after the sphincterotomy. Both overt and occult bleeding...
Eligibility Criteria
Inclusion
- Consecutive patients undergoing ERCP who will require sphincterotomy
Exclusion
- Previous sphincterotomy/papillotomy
- Previous Polya gastrectomy
- Patients on maintenance PPI
- Pregnant and lactating women
- Age \<18 years
- Previous liver transplant
- unable to consent for study
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
185 Patients enrolled
Trial Details
Trial ID
NCT01873079
Start Date
April 1 2013
End Date
June 1 2016
Last Update
July 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, China